4basebio (4BB) Competitors

4basebio (LON:4BB) and PureTech Health (LON:PRTC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

Do analysts rate 4BB or PRTC?

4basebio currently has a consensus price target of GBX 1,600, suggesting a potential upside of 81.51%. PureTech Health has a consensus price target of GBX 455, suggesting a potential upside of 228.28%. Given PureTech Health's higher probable upside, analysts clearly believe PureTech Health is more favorable than 4basebio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
4basebio	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
PureTech Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals and insiders hold more shares of 4BB or PRTC?

2.0% of 4basebio shares are held by institutional investors. Comparatively, 79.9% of PureTech Health shares are held by institutional investors. 68.4% of 4basebio shares are held by company insiders. Comparatively, 15.9% of PureTech Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has more risk & volatility, 4BB or PRTC?

4basebio has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, PureTech Health has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500.

Is 4BB or PRTC more profitable?

4basebio has a net margin of 0.00% compared to PureTech Health's net margin of -17,620.94%. PureTech Health's return on equity of -21.15% beat 4basebio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
4basebio	N/A	-231.29%	-54.30%
PureTech Health	-17,620.94%	-21.15%	-13.39%

Does the media favor 4BB or PRTC?

In the previous week, PureTech Health had 2 more articles in the media than 4basebio. MarketBeat recorded 3 mentions for PureTech Health and 1 mentions for 4basebio. 4basebio's average media sentiment score of 0.00 equaled PureTech Health'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
4basebio	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
PureTech Health	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger valuation & earnings, 4BB or PRTC?

4basebio has higher earnings, but lower revenue than PureTech Health. 4basebio is trading at a lower price-to-earnings ratio than PureTech Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
4basebio	£311K	363.09	-£9.84M	-£0.78	-1,130.13
PureTech Health	£521.32K	798.60	-£91.86M	-£24.38	-5.69

Summary

PureTech Health beats 4basebio on 8 of the 13 factors compared between the two stocks.